top of page
84770f_68a07779fe514e93b3876e8ff37f34c4~mv2_edited.png

ASX:NUF

Nufarm Ltd

Investment Summary

The fund managers believe that Nufarm Ltd has faced significant challenges due to drier weather conditions and a decline in on-farm purchases by farmers, resulting in a contraction in demand for crop protection products. Despite announcing a ~5% downgrade to EBITDA guidance for FY23, they view this outcome as relatively strong, especially compared to peers facing negative earnings impacts of over 20%. The fund managers express confidence that Nufarm is a higher quality business than in previous years, bolstered by the company's focus on high-margin, high-growth proprietary formulations in its crop protection segment. Additionally, Nufarm's seeds division is expected to experience strong earnings growth, driven by innovations like Omega-3 and Carinata traits. Overall, they anticipate a return to normalised ordering patterns as agricultural conditions improve.

feedback.png

Commentary From The Managers

L1 Capital

31 Dec 2023

$5.29

  • Seed technologies segment within Nufarm Group has achieved a CAGR of 49% p.a. over the past three years.
  • This segment now accounts for 20% of group earnings.
  • Nufarm aims to grow EBITDA in this segment to ~$150m by FY26 and over ~$400m by FY30.
  • A significant driver of growth is the proprietary Omega-3 seed technology.
  • This technology offers a sustainable and scalable solution to meet the increasing Omega-3 demand from the fish farming industry.

L1 Capital

31 Dec 2023

$5.29

  • Nufarm shares have recovered by 10% following solid FY23 results despite challenging weather and destocking.
  • Improved agricultural conditions and a return to normal inventory levels are supportive of future ordering patterns.
  • L1 Capital views Nufarm as a higher-quality business compared to previous years.
  • Augmentation of crop protection business with high-margin proprietary formulations is in progress.
  • Nufarm's seeds division is commercializing new traits such as Omega-3 and Carinata, expected to drive earnings growth.
  • L1 Capital continues to hold Nufarm due to these positive developments and growth prospects.

L1 Capital

31 Oct 2023

$4.33

  • Nufarm (Long -9%) shares have declined alongside global agriculture peers due to adverse weather conditions.
  • A decrease in on-farm purchases by farmers has been observed, shifting from inventory build-up during COVID-19 to just-in-time purchasing.
  • Significant contraction in demand for crop protection products, especially in North America, is noted as inventories are adjusted.
  • Nufarm announced a ~5% downgrade to EBITDA guidance for FY23, reflecting the challenging operating environment.
  • This performance is considered relatively strong, especially compared to peers experiencing negative earnings impacts of >20%.
  • L1 Capital views Nufarm as a higher-quality business than in previous years.
  • The company is enhancing its crop protection operations with high-margin, high-growth proprietary formulations.
  • Nufarm’s seeds business is commercializing innovative traits like Omega-3 and Carinata, aiming for strong earnings growth.

L1 Capital

30 Sept 2023

$4.73

  • Nufarm (Long -8%) shares decreased, reflecting broader trends in global agriculture.
  • Decline attributed to drier weather conditions and reduced on-farm purchases.
  • Post-COVID-19, farmers shifted to just-in-time purchasing for crop inputs amidst falling prices and normalised supply chains.
  • Significant contraction in demand for crop protection products, especially in North America.
  • Nufarm announced a ~5% downgrade to FY23 EBITDA guidance due to operating challenges.
  • Despite these challenges, this outcome is viewed as relatively strong, with peers facing negative impacts of 20% or more.
  • Nufarm is now seen as a higher quality business compared to previous years.
  • The company is enhancing its crop protection segment with high-margin, high-growth proprietary formulations.
  • Nufarm's seeds business is commercialising exciting traits like Omega-3 and Carinata, projecting strong earnings growth.

L1 Capital

30 Sept 2023

$4.73

  • Nufarm shares have declined along with global agriculture peers due to drier weather conditions.
  • There has been a reduction in on-farm purchases by farmers.
  • Farmers are shifting to just-in-time purchasing for key crop inputs as prices fall and supply chains normalise.
  • This shift has led to a significant contraction in demand for crop protection products, especially in North America.
  • Nufarm announced a ~5% downgrade to EBITDA guidance for FY23 due to the challenging operating environment.
  • L1 Capital views this as a relatively strong performance given major industry headwinds, which are considered transitory.
  • Nufarm has much higher quality business attributes compared to a few years ago.
  • The company is enhancing its crop protection business with high-margin, high-growth proprietary formulations.
  • Nufarm’s seeds business has commercialised exciting traits like Omega-3 and Carinata, expected to drive strong earnings growth.

Please note: The completeness, accuracy or current status of the investments referenced are not guaranteed. 

Subscribe

Join the email list for updates.

Thanks for submitting!

Thesis-Tracker.com aggregates insights from financial services professionals exclusively for informational and educational purposes. Thesis-Tracker.com does not publish proprietary opinions nor does Thesis-Tracker.com enter into commercial arrangements with any of the featured financial services professionals. Before making a decision please consider these and any relevant Product Disclosure Statement. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs.

bottom of page